, Volume 58, Supplement 2, pp 269–270 | Cite as

Pharmacodynamics of Trovafloxacin vs Ceftriaxone in Streptococcus pneumoniae

  • Philip D. Lister
  • Christine C. Sanders
Poster Presentations Extended Abstract


  1. 1.
    Musher DM. Streptococcus pneumonias. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practices of Infectious Diseases. New York: Churchill Livingston, New York, 1995: 1811–26Google Scholar
  2. 2.
    Lister PD. Multiply-resistant pneumococcus: therapeutic problems in the management of serious infections. Eur J Clin Micro Infect Dis 1995; 14(1): 18–25CrossRefGoogle Scholar
  3. 3.
    Neu HC, Chin N. In vitro activity of the new fluoroquinolone CP-99,219. Antimicrob Agents Chemother 1994; 38: 2615–22PubMedCrossRefGoogle Scholar
  4. 4.
    Lister PD, Sanders WE Jr., Sanders CC. Cefepime-aztreonam: a unique double β-lactam combination for Pseudomonas aeruginosa. Antimicrob Agents Chemother 1998; 42: 1610–9PubMedGoogle Scholar

Copyright information

© Adis International Limited 1999

Authors and Affiliations

  • Philip D. Lister
    • 1
  • Christine C. Sanders
    • 1
  1. 1.Center for Research in Anti-Infectives and Biotechnology, Department of Medical Microbiology & ImmunologyCreighton University School of MedicineOmahaUSA

Personalised recommendations